295 related articles for article (PubMed ID: 24021426)
1. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
[TBL] [Abstract][Full Text] [Related]
2. Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure.
Mutanen A; Lohi J; Heikkilä P; Jalanko H; Pakarinen MP
J Hepatol; 2015 Jun; 62(6):1391-7. PubMed ID: 25595885
[TBL] [Abstract][Full Text] [Related]
3. Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure.
Mutanen A; Lohi J; Heikkilä P; Koivusalo AI; Rintala RJ; Pakarinen MP
Hepatology; 2013 Aug; 58(2):729-38. PubMed ID: 23460496
[TBL] [Abstract][Full Text] [Related]
4. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
[TBL] [Abstract][Full Text] [Related]
5. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure.
Hukkinen M; Kivisaari R; Lohi J; Heikkilä P; Mutanen A; Merras-Salmio L; Pakarinen MP
Liver Int; 2016 Mar; 36(3):361-9. PubMed ID: 26058319
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Microbiota Signatures Associated With Histological Liver Steatosis in Pediatric-Onset Intestinal Failure.
Korpela K; Mutanen A; Salonen A; Savilahti E; de Vos WM; Pakarinen MP
JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):238-248. PubMed ID: 25934046
[TBL] [Abstract][Full Text] [Related]
7. Histopathological liver steatosis linked with high parenteral glucose and amino acid supply in infants with short bowel syndrome.
Gunnar R; Mutanen A; Merras-Salmio L; Pakarinen MP
JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):41-50. PubMed ID: 35633305
[TBL] [Abstract][Full Text] [Related]
8. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
9. Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure.
Mutanen A; Nissinen MJ; Lohi J; Heikkilä P; Gylling H; Pakarinen MP
Am J Clin Nutr; 2014 Oct; 100(4):1085-94. PubMed ID: 25099547
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure.
Kurvinen A; Nissinen MJ; Gylling H; Miettinen TA; Lampela H; Koivusalo AI; Rintala RJ; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):440-6. PubMed ID: 21543999
[TBL] [Abstract][Full Text] [Related]
14. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.
Fragkos KC; Picasso Bouroncle MC; Kumar S; Caselton L; Menys A; Bainbridge A; Taylor SA; Torrealdea F; Kumagai T; Di Caro S; Rahman F; Macnaughtan J; Chouhan MD; Mehta S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32707726
[TBL] [Abstract][Full Text] [Related]
15. Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure.
Mutanen A; Pakarinen MP
Clin Nutr; 2017 Oct; 36(5):1349-1354. PubMed ID: 27663542
[TBL] [Abstract][Full Text] [Related]
16. Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study.
Yan H; Xia M; Chang X; Xu Q; Bian H; Zeng M; Rao S; Yao X; Tu Y; Jia W; Gao X
PLoS One; 2011; 6(9):e24895. PubMed ID: 21949781
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
[TBL] [Abstract][Full Text] [Related]
19. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
20. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
Chen XL; Han YD; Wang H
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
